Rincon Bio performs MOLM-13 xenograft models to test efficacy of preclinical therapies. Please see below for additional information or to request a quote.
MOLM-13 were derived from the peripheral blood of a patient with acute monocytic leukemia
Used in xenografts to test the efficacy of novel cancer therapeutics. Tumors develop after being injected into the flank of immunocompromised mice.
Rincon Bio Growth Curve
Cell Line: MOLM-13
Mouse Strain: Athymic nude Fox1nu [Hsd] (Envigo, Cat. 6902)
Animals per Group: 10
Positive Control: N/A
Dosing schedule: N/A
Stratification size: 200mm^3
Days from implant to stratification: 10
Cells Implanted per Animal: 10 million
WHY WORK WITH
When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices
Most efficacy studies can be initiated within two business days.
We love our clients! We are flexible and easy to work with. And we take a personal interest in our clients' studies.